Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.98 USD | -0.54% | -4.75% | +12.78% |
Apr. 17 | Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 | MT |
Apr. 17 | Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.78% | 52.04B | |
+2.50% | 207B | |
+1.41% | 175B | |
+9.84% | 132B | |
+16.40% | 99.1B | |
-3.42% | 60.89B | |
-6.61% | 45.48B | |
-4.00% | 38.81B | |
+9.18% | 38.77B | |
+3.74% | 26.09B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Barclays Starts Edwards Lifesciences at Overweight With $96 Price Target